Economic and Clinical Effects of Evaluating Rapid Viral Response to Peginterferon alfa-2b Plus Ribavirin for the Initial Treatment of Chronic Hepatitis CJB Wong et al. Am J Gastroenterol 98 (11), 2354-62. PMID 14638334. - Clinical TrialAssessment of 12-wk viral response in genotype 1, hepatitis C infected patients should reduce peginterferon plus ribavirin morbidity and costs and improve its cost-effect …
[The Factors Associated With Viral Relapse After Interferon Treatment in Chronic Hepatitis C Patients]L Ma et al. Zhonghua Gan Zang Bing Za Zhi 14 (8), 565-8. PMID 16938164.The viral relapse of chronic hepatitis C patients after IFN treatment was significantly associated with the genotypes of the HCV.
A Brief History of Hepatitis MilestonesC Trepo. Liver Int 34 Suppl 1, 29-37. PMID 24373076. - ReviewHepatitis has been a major plague of mankind. The history of the discovery of causative viruses is one of the most fascinating scientific adventures of this half century. …
Progress in Diagnosis of Hepatitis and the Cirrhotic LiverJG Szakacs et al. Ann Clin Lab Sci 29 (2), 87-103. PMID 10219695.History of the concept and definition of hepatitis is briefly reviewed. The landmarks of progress are based on better understanding of liver structure and introduction of …
Viral Hepatitis Control in China. A Brief Review on the Present Status of Viral Hepatitis in ChinaZH Li. Chin Med J (Engl) 105 (3), 179-82. PMID 1395835. - Review
Cited by 1 PubMed Central articles
Success of Direct-Acting, Antiviral-Based Therapy for Chronic Hepatitis C Is Not Affected by Type 2 DiabetesBA Niccum et al. Clin Diabetes 38 (1), 40-46. PMID 31975750.Chronic hepatitis C virus (HCV) is a risk factor for type 2 diabetes. In the era of interferon-based HCV therapy, type 2 diabetes was associated with decreased likelihood …